Analysts Set Sanofi (NASDAQ:SNY) Target Price at $62.67

Sanofi (NASDAQ:SNY) has received an average recommendation of “Hold” from the thirteen ratings firms that are currently covering the company, Marketbeat Ratings reports. Eight research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $62.6667.

Several equities analysts recently commented on the company. TD Cowen restated a “hold” rating on shares of Sanofi in a research report on Tuesday, December 30th. Jefferies Financial Group reissued a “buy” rating on shares of Sanofi in a report on Monday, October 27th. Barclays cut shares of Sanofi from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, January 6th. HSBC restated a “buy” rating on shares of Sanofi in a research report on Wednesday, December 10th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Sanofi in a research note on Friday, January 16th.

Hedge Funds Weigh In On Sanofi

Several institutional investors and hedge funds have recently modified their holdings of the stock. Flagship Harbor Advisors LLC purchased a new stake in Sanofi in the 4th quarter valued at about $25,000. Financial Consulate Inc. purchased a new stake in Sanofi during the 3rd quarter worth about $26,000. Ameritas Advisory Services LLC purchased a new position in Sanofi during the second quarter valued at approximately $28,000. Measured Wealth Private Client Group LLC purchased a new stake in shares of Sanofi in the third quarter worth $29,000. Finally, Palisade Asset Management LLC bought a new position in Sanofi in the third quarter valued at $30,000. 14.03% of the stock is currently owned by institutional investors and hedge funds.

Sanofi Trading Up 1.3%

NASDAQ:SNY opened at $49.25 on Monday. The stock has a market cap of $120.12 billion, a price-to-earnings ratio of 13.68, a PEG ratio of 1.26 and a beta of 0.45. The business has a fifty day moving average of $47.84 and a 200-day moving average of $48.63. Sanofi has a 1 year low of $44.62 and a 1 year high of $60.12. The company has a debt-to-equity ratio of 0.20, a quick ratio of 0.29 and a current ratio of 1.09.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.